SEROEPIDEMIOLOGICAL STUDY OF STRONGYLOIDIASIS IN PATIENTS TAKING IMMUNOSUPPRESSIVE DRUGS IN BUSHEHR, IRAN, 2012

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

FOULADVAND MORADALI; BARAZESH AFSHIN; TAHMASEBI RAHIM

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Mazandaran University of Medical Sciences Year:2017 | Volume:27 | Issue:149 Page(s): 187-191

Download Full-Text

Persian Verion

View:

876

Download:

Cites:

Information Journal Paper

Title

SEROEPIDEMIOLOGICAL STUDY OF STRONGYLOIDIASIS IN PATIENTS TAKING IMMUNOSUPPRESSIVE DRUGS IN BUSHEHR, IRAN, 2012

Author(s)

FOULADVAND MORADALI | BARAZESH AFSHIN | TAHMASEBI RAHIM | Issue Writer Certificate

Keywords

STRONGYLOIDIASISQ1

CHEMOTHERAPYQ1

HEMODIALYSISQ2

BUSHEHRQ2

IRANQ2

Abstract

Background and purpose: STRONGYLOIDIASIS is a nematode infection of humans with a worldwide distribution which is more prevalent in tropical and subtropical regions. Infected people are often clinically asymptomatic, however, in untreated immunosuppressed patients, it causes more than 80% mortality. So, the accurate and timely diagnosis of infection can prevent patient's death. This study was conducted to determine the prevalence of STRONGYLOIDIASIS in patients under CHEMOTHERAPY and HEMODIALYSIS in BUSHEHR, IRAN.Materials and methods: We performed a cross-sectional study in 2011-2012 in which all CHEMOTHERAPY and HEMODIALYSIS patients were evaluated by ELISA method to determine the presence of anti-Strongyloides stercoralis IgG antibody.Results: A total of 214 individuals were studied from whom 4 (1.9%) patients under CHEMOTHERAPY and 3 (1.4%) HEMODIALYSIS patients were positive for IgG antibody.Conclusion: STRONGYLOIDIASIS is as a life-threatening risk factor in people under CHEMOTHERAPY and HEMODIALYSIS, therefore, STRONGYLOIDIASIS screening is suggested in these patients before administering immunosuppressive drugs, dialysis, and kidney transplant.

Cites

No record.

References

PREVALENCE OF STRONGYLOIDES STERCORALIS AND OTHER INTESTINAL PARASITES IN REHABILITATION CENTERS IN MAZANDARAN PROVINCE, NORTHERN IRAN

Cite

APA: Copy

FOULADVAND, MORADALI, BARAZESH, AFSHIN, & TAHMASEBI, RAHIM. (2017). SEROEPIDEMIOLOGICAL STUDY OF STRONGYLOIDIASIS IN PATIENTS TAKING IMMUNOSUPPRESSIVE DRUGS IN BUSHEHR, IRAN, 2012. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, 27(149), 187-191. SID. https://sid.ir/paper/45449/en

Vancouver: Copy

FOULADVAND MORADALI, BARAZESH AFSHIN, TAHMASEBI RAHIM. SEROEPIDEMIOLOGICAL STUDY OF STRONGYLOIDIASIS IN PATIENTS TAKING IMMUNOSUPPRESSIVE DRUGS IN BUSHEHR, IRAN, 2012. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2017;27(149):187-191. Available from: https://sid.ir/paper/45449/en

IEEE: Copy

MORADALI FOULADVAND, AFSHIN BARAZESH, and RAHIM TAHMASEBI, “SEROEPIDEMIOLOGICAL STUDY OF STRONGYLOIDIASIS IN PATIENTS TAKING IMMUNOSUPPRESSIVE DRUGS IN BUSHEHR, IRAN, 2012,” JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, vol. 27, no. 149, pp. 187–191, 2017, [Online]. Available: https://sid.ir/paper/45449/en

Related Journal Papers